Playback speed
10 seconds
CAMBRIA-1 Study: Extended Adjuvant Therapy With Camizestrant vs. Standard ET in Patients With ER+/HER2- Early BC and an Intermediate or High Risk of Recurrence
31 views
November 3, 2023
Login to view comments.
Click here to Login